Výsledky vyhledávání

Akademický článek

Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention

Autor: Majd Z, Mohan A, Johnson ML, Essien EJ, Barner JC, Serna O, Gallardo E, Fleming ML, Ordonez N, Holstad MM, Abughosh SM

Publikováno v: Patient Preference and Adherence, Vol Volume 16, Pp 2739-2748 (2022)

Zahra Majd,1 Anjana Mohan,1 Michael L Johnson,1 Ekere J Essien,1 Jamie C Barner,2 Omar Serna,3 Esteban Gallardo,3 Marc L Fleming,4 Nancy Ordonez,5 Marcia M Holstad,6 Susan M Abughosh1 1Department of Pharmaceutical Health Outcomes and Policy, Universi

Externí odkaz: https://doaj.org/article/e0f687f09e7a4bce9352dcb4bdf3507a

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis

Autor: Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR

Publikováno v: Patient Preference and Adherence, Vol Volume 14, Pp 2187-2199 (2020)

Jagadeswara R Earla,1 George J Hutton,2 J Douglas Thornton,1 Hua Chen,1 Michael L Johnson,1 Rajender R Aparasu1 1Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX, USA; 2Department of Neurology, Baylor

Externí odkaz: https://doaj.org/article/61b8cffe770f4c32909ff3be73b0bfde

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs)

Autor: Paranjpe R, Johnson ML, Essien EJ, Barner JC, Serna O, Gallardo E, Majd Z, Fleming ML, Ordonez N, Holstad MM, Abughosh SM

Publikováno v: Patient Preference and Adherence, Vol Volume 14, Pp 1935-1947 (2020)

Rutugandha Paranjpe,1 Michael L Johnson,1 Ekere J Essien,1 Jamie C Barner,2 Omar Serna,3 Esteban Gallardo,3 Zahra Majd,1 Marc L Fleming,4 Nancy Ordonez,1 Marcia M Holstad,5 Susan M Abughosh1 1Pharmaceutical Health Outcomes and Policy, University of H

Externí odkaz: https://doaj.org/article/ceb9bb985aba480faf24a2b837acfdba

Zobrazit plný text záznamu

Akademický článek

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression

Autor: Chekani F, Holmes HM, Johnson ML, Chen H, Sherer JT, Aparasu RR

Publikováno v: Drug, Healthcare and Patient Safety, Vol Volume 12, Pp 23-30 (2020)

Farid Chekani,1 Holly M Holmes,2 Michael L Johnson,1 Hua Chen,1 Jeffrey T Sherer,1 Rajender R Aparasu1 1Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204-5047, USA; 2Division of Ger

Externí odkaz: https://doaj.org/article/4d65c2d2cc3c49f2aebefecdf6ef1c9c

Zobrazit plný text záznamu

University life and wellbeing : the association between financial factors and students‚ÄövÑv¥ academic aspirations

Autor: Johnson, ML

University has an increasingly significant role in positively shaping students‚ÄövÑv¥ life outcomes. Established theoretical models and past research indicate that income and financial stressors can impact students‚ÄövÑv¥ academic aspirat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fdff8b545c6c21333f56a85408d2b06

Zobrazit plný text záznamu

Akademický článek

EPH140 Comparative Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparins in Cancer Associated Thrombosis

Autor: Yande, S ¹, Johnson, ML ², Aparasu, RR ², Toale, K ³, Wanat, M ⁴

Publikováno v: In Value in Health June 2024 27(6) Supplement:S179-S179

Zobrazit plný text záznamu

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study

Autor: Cho BC, Abreu DR, Hussein M, Cobo M, Patel AJ, Secen N, Lee KH, Massuti B, Hiret S, Yang JCH, Barlesi F, Lee DH, Ares LP, Hsieh RW, Patil NS, Twomey P, Yang X, Meng R, Johnson ML

Publikováno v: LANCET ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

BACKGROUND: Targeted inhibition of the PD-L1-PD-1 pathway might be further amplified through combination of PD-1 or PD-L1 inhibitors with novel anti-TIGIT inhibitory immune checkpoint agents, such as tiragolumab. In the CITYSCAPE trial, we aimed to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::150df734ff69c9b47d6f1c2e45c89351
https://linkinghub.elsevier.com/retrieve/pii/S1470-2045(22)00226-1

Zobrazit plný text záznamu